CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure

Eeva Kettunen, Sauli Savukoski, Kaisa Salmenkivi, Tom Böhling, Esa Vanhala, Eeva Kuosma, Sisko Anttila, Henrik Wolff

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number507
JournalBMC Cancer
Volume19
Number of pages10
ISSN1471-2407
DOIs
Publication statusPublished - 28 May 2019
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Malignant pleural mesothelioma
  • CDKN2A
  • p16
  • Tumor stroma
  • Asbestos exposure
  • IN-SITU HYBRIDIZATION
  • HOMOZYGOUS DELETION
  • P16/CDKN2A DELETION
  • GENOMIC ALTERATIONS
  • PROGNOSTIC-FACTORS
  • TUMOR-SUPPRESSOR
  • 9P21 DELETION
  • DIAGNOSIS
  • GENE
  • LUNG
  • 3122 Cancers

Cite this

Kettunen, Eeva ; Savukoski, Sauli ; Salmenkivi, Kaisa ; Böhling, Tom ; Vanhala, Esa ; Kuosma, Eeva ; Anttila, Sisko ; Wolff, Henrik. / CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure. In: BMC Cancer. 2019 ; Vol. 19.
@article{8bab77ce23b14d9ebe4a149253d22ea0,
title = "CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure",
keywords = "Malignant pleural mesothelioma, CDKN2A, p16, Tumor stroma, Asbestos exposure, IN-SITU HYBRIDIZATION, HOMOZYGOUS DELETION, P16/CDKN2A DELETION, GENOMIC ALTERATIONS, PROGNOSTIC-FACTORS, TUMOR-SUPPRESSOR, 9P21 DELETION, DIAGNOSIS, GENE, LUNG, 3122 Cancers",
author = "Eeva Kettunen and Sauli Savukoski and Kaisa Salmenkivi and Tom B{\"o}hling and Esa Vanhala and Eeva Kuosma and Sisko Anttila and Henrik Wolff",
year = "2019",
month = "5",
day = "28",
doi = "10.1186/s12885-019-5652-y",
language = "English",
volume = "19",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BMC",

}

CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure. / Kettunen, Eeva; Savukoski, Sauli; Salmenkivi, Kaisa; Böhling, Tom; Vanhala, Esa; Kuosma, Eeva; Anttila, Sisko; Wolff, Henrik.

In: BMC Cancer, Vol. 19, 507, 28.05.2019.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure

AU - Kettunen, Eeva

AU - Savukoski, Sauli

AU - Salmenkivi, Kaisa

AU - Böhling, Tom

AU - Vanhala, Esa

AU - Kuosma, Eeva

AU - Anttila, Sisko

AU - Wolff, Henrik

PY - 2019/5/28

Y1 - 2019/5/28

KW - Malignant pleural mesothelioma

KW - CDKN2A

KW - p16

KW - Tumor stroma

KW - Asbestos exposure

KW - IN-SITU HYBRIDIZATION

KW - HOMOZYGOUS DELETION

KW - P16/CDKN2A DELETION

KW - GENOMIC ALTERATIONS

KW - PROGNOSTIC-FACTORS

KW - TUMOR-SUPPRESSOR

KW - 9P21 DELETION

KW - DIAGNOSIS

KW - GENE

KW - LUNG

KW - 3122 Cancers

U2 - 10.1186/s12885-019-5652-y

DO - 10.1186/s12885-019-5652-y

M3 - Article

VL - 19

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

M1 - 507

ER -